Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by bilosellhion Jun 05, 2003 6:16pm

237 Views

Post# 6147160

RE: torii - can you tell us why?

looks like perhaps people are dumping onc and moving into biotechs that are moving up. since may 27, when over 1.2M shares were traded on the tsx and over 675K on nasdaq, volume has steadily fallen, together with the price - and on the one day it actually managed to close higher on the tsx, the volume was the lowest its been for over a week. looks like its heading still lower if there isn't any follow-up or follow-through on the part of management. ps anyone know why BT's AGM audio presentation was removed from onc's website?

Bullboard Posts

Debt-free cannabis company set for next stage of growth